Table 2 IOP, antiglaucoma medications, LogMAR and changes in BCVAa
Variable | Study Group (N = 19) | Control group (N = 19) | P-value |
|---|---|---|---|
Baseline | |||
IOP, mmHg | 14.05 (±4.3) | 12.16 (±3.4) | 0.14 |
No. of medications | 0.42 (±0.7) | 0.46 (±0.5) | 0.27 |
LogMAR | 0.74 (±0.6) | 0.71 (±0.6) | 0.90 |
BCVA 20/40 or better | 4 (21.1%) | 4 (21.1%) | 0.90 |
BCVA worse than 20/40 | 15 (78.9%) | 15 (78.9%) | |
No. of eyes | 19 | 19 | |
3 Months postoperative | |||
IOP, mmHg | 14.73 (±4.3) | 12.46 (±8.9) | 0.92 |
(P-value)b | (p = 0.18) | (p = 0.31) | |
No. of medications | 0.53 (±0.6) | 0.63 (±1.0) | 0.76 |
(P-value)b | (p = 0.30) | (p = 0.11) | |
LogMAR | 0.68 (±0.2) | 0.84 (±1.0) | 0.55 |
(P-value)b | (p = 0.29) | (p = 0.70) | |
BCVA 20/40 or better | 9 (47.4%) | 5 (26.3%) | 0.16 |
BCVA worse than 20/40 | 10 (52.6%) | 14 (73.7%) | |
No. of eyes | 17 | 19 | |
12 Months postoperative | |||
IOP, mmHg | 17.00 (±6.8) | 13.00 (±6.1) | 0.25 |
(P-value)b | (p = 0.36) | (p = 0.27) | |
No. of medications | 1.08 (±1.6) | 0.62 (±0.9) | 0.16 |
(P-value)b | (p = 0.02) | (p = 0.21) | |
LogMAR | 0.78 (±0.6) | 0.85 (±0.8) | 0.81 |
(P-value)b | (p = 0.42) | (p = 0.32) | |
BCVA 20/40 or better | 10 (52.6%) | 5 (26.3%) | 0.29 |
BCVA worse than 20/40 | 9 (47.4%) | 14 (73.7%) | |
No. of eyes | 13 | 15 | |
24 Months postoperative | |||
IOP, mmHg | 13.71 (±3.6) | 12.00 (±5.8) | 0.42 |
(P-value)b | (p = 0.35) | (p = 0.91) | |
No. of medications | 1.00 (±1.2) | 0.52 (±0.7) | 0.04 |
(P-value)b | (p = 0.04) | (p = 0.54) | |
LogMAR | 0.72 (±0.8) | 0.77 (±0.9) | 0.69 |
(P-value)b | (p = 0.39) | (p = 0.40) | |
BCVA 20/40 or better | 10 (52.6%) | 6 (31.6%) | 0.21 |
BCVA worse than 20/40 | 9 (47.4%) | 13 (68.4%) | |
No. of eyes | 9 | 11 | |
36 Months postoperative | |||
IOP, mmHg | 14.80 (±1.3) | 13.50 (±7.5) | 0.71 |
(P-value)b | (p = 0.88) | (p = 0.75) | |
No. of medications | 1.00 (±1.7) | 0.50 (±0.8) | 0.02 |
(P-value)b | (p = 0.03) | (p = 0.74) | |
LogMAR | 0.79 (±0.7) | 0.81 (±0.8) | 0.51 |
(P-value)b | (p = 0.47) | (p = 0.29) | |
BCVA 20/40 or better | 9 (47.4%) | 6 (31.6%) | 0.30 |
BCVA worse than 20/40 | 10 (52.6%) | 13 (68.4%) | |
No. of eyes | 6 | 6 | |
Last visit | |||
IOP, mmHg | 14.21 (±5.8) | 12.61 (±6.1) | 0.29 |
(P-value)b | (p = 0.92) | (p = 0.91) | |
No. of medications | 1.58 (±1.5) | 0.53 (±1.0) | 0.02 |
(P-value)b | (p = 0.02) | (p = 0.17) | |
LogMAR | 0.78 (±0.9) | 0.92 (±1.0) | 0.69 |
(P-value)b | (p = 0.84) | (p = 0.59) | |
BCVA 20/40 or better | 9 (47.4%) | 7 (36.8%) | 0.37 |
BCVA worse than 20/40 | 10 (52.6%) | 12 (63.2%) | |